Interpreting the POTOMAC Trial: Evaluating Durvalumab in BCG-Naïve NMIBC | Urology Times
Interpreting the POTOMAC Trial: Evaluating Durvalumab in BCG-Na…
2 months ago
urologytimes.com
Imfinzi (durvalumab) vedlejší účinky, interakce, použití a otisk drogy - Zdraví 2026
Imfinzi (durvalumab) vedlejší účinky, interakce, použití a otisk drogy - Z…
Aug 24, 2019
oldmedic.com
Tips for Managing NSCLC Patients on Durvalumab Therapy | OncLive
Tips for Managing NSCLC Patients on Durvalumab Therapy | OncLive
Mar 13, 2018
onclive.com
How Durvalumab Has Changed the Standard of Care | OncLive
How Durvalumab Has Changed the Standard of Care | OncLive
3 months ago
onclive.com
Real-World Use of Durvalumab Tremelimumab in Advanced HCC | OncLive
Real-World Use of Durvalumab Tremelimumab in Advanced HCC …
Oct 28, 2022
onclive.com
Recommended Settings for Durvalumab Treatment | OncLive
Recommended Settings for Durvalumab Treatment | OncLive
May 2, 2019
onclive.com
Treating for Stage III NSCLC After Progression on Durvalumab | OncLive
Treating for Stage III NSCLC After Progression on Durvalumab | Onc…
Jul 13, 2020
onclive.com
Dr. Zandberg on Durvalumab Trial in Head and Neck Cancer | OncLive
Sep 22, 2017
onclive.com
AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemot…
May 19, 2023
onclive.com
Highlights of Durvalumab for Advanced Bladder Cancer | OncLive
Apr 22, 2017
onclive.com
FDA Approval of Durvalumab for Advanced Bladder Cancer | OncLive
Apr 22, 2017
onclive.com
Dr. Siefker-Radtke on FDA Approval of Durvalumab in Bladder Cancer …
May 2, 2017
onclive.com
Implications for Using Durvalumab in Stage 3 NSCLC | OncLive
1 week ago
onclive.com
Durvalumab in Stage III NSCLC Based on Performance Status | On…
Jul 13, 2020
onclive.com
Dr. Langer on the Benefit of Durvalumab in Stage III NSCLC | O…
May 29, 2019
onclive.com
A New Immunotherapy for Bladder Cancer
Dec 29, 2019
aacr.org
PACIFIC Trial: Durvalumab Following Chemotherapy for Stag…
Jul 13, 2020
onclive.com
ELCC 2025 Insights: SAKK 16/14 Trial - The Effectiveness of Periop…
4 months ago
vumedi.com
ESMO GI 2025 Insights: Phase 3b SIERRA Study - Durvalumab & Tre…
47 views7 months ago
vumedi.com
WCLC 2024 Insights: PACIFIC-BRAZIL Study - Intensified Chem…
51 viewsSep 23, 2024
vumedi.com
Dr. Joshi Discusses Durvalumab and Radiation Therapy in Bladder …
Feb 9, 2018
onclive.com
Dr. Powles Discusses the Future of Durvalumab in Bladder Cancer | O…
Mar 8, 2017
onclive.com
2:30
In patients with muscle-invasive bladder cancer, recurrences after …
1.7K viewsNov 13, 2024
FacebookThe New England Journal of Medicine
Durvalumab in LS-SCLC: Exploring Phase 3 ADRIATIC Trial Outcome…
3 weeks ago
onclive.com
2:08
No new advances in systemic treatments for limited-stage small …
1.7K viewsOct 14, 2024
FacebookThe New England Journal of Medicine
NSCLC Care: Evaluating Durvalumab in the First-Line Setting
Dec 28, 2023
reachmd.com
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab S…
Feb 10, 2018
onclive.com
HIMALAYA Trial: First-Line Tremelimumab Plus Durvalumab I…
Oct 2, 2022
ascopost.com
EMERALD-3: tremelimumab durvalumab with or without lenvat…
Sep 10, 2022
vjoncology.com
Dr. Kato on the Rationale For Investigating Dato-DXd Plus Durv…
Sep 20, 2023
onclive.com
See more videos
Static thumbnail place holder